Profil
John Paul O'Connor is currently a Director at Fragile X Association of Australia and a Member at Australian Institute of Co. Directors.
Previously, he was the Chairman at Kazia Therapeutics Ltd. from 2016 to 2017 and an Independent Non-Executive Director at Memphasys Ltd. from 2011 to 2012.
Postes actifs de John Paul O'Connor
| Sociétés | Poste | Début |
|---|---|---|
Fragile X Association of Australia | Directeur/Membre du Conseil | - |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Anciens postes connus de John Paul O'Connor
| Sociétés | Poste | Fin |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Président | 08/06/2017 |
| MEMPHASYS LIMITED | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kazia Therapeutics Ltd.
Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Memphasys Ltd.
Memphasys Ltd. BiotechnologyHealth Technology Operates as an investment holding company with interest in development and distribution of biological products | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Fragile X Association of Australia |
















